Compliance6 min read
What HRSA Is Actually Looking For in a 340B Audit
HRSA audits follow a predictable pattern — but most covered entities don't prepare for what auditors actually scrutinize. A breakdown of the most common findings and how to address them before the notice arrives.
Read article→
Contract Pharmacy8 min read
Manufacturer Restrictions: A Financial Impact Framework
Manufacturer restrictions on contract pharmacy claims have reshaped the 340B landscape. Here's how to quantify the financial impact on your program and build a response strategy that holds up.
Read article→
Financial Analysis5 min read
The 340B Savings Leakage Problem No One Talks About
Most covered entities know their gross 340B savings figure. Far fewer know how much of it is actually reaching the program's intended purpose — and why the gap is larger than they think.
Read article→
Compliance7 min read
Patient Definition: The Most Litigated Concept in 340B
No single issue generates more audit findings than patient definition. A plain-language guide to what the guidance actually requires, where covered entities go wrong, and how to build a defensible standard.
Read article→
Contract Pharmacy6 min read
Renegotiating Your Contract Pharmacy Agreements: A Checklist
Contract pharmacy agreements signed three years ago may no longer reflect the current landscape. The key terms to revisit, the benchmarks to use, and the leverage points most covered entities overlook.
Read article→
Financial Analysis9 min read
How to Present 340B Value to Your CFO and Board
Leadership wants to understand what the 340B program is worth — in dollars, not compliance status. A framework for translating program economics into the financial language executives actually use.
Read article→